Recurrent PTPRZ1‐MET fusion and a high occurrence rate of MET exon 14 skipping in brain metastases

Identifying molecular features is an essential component of the management and targeted therapy of brain metastases (BMs). The molecular features are different between primary lung cancers and BMs of lung cancer. Here we report the DNA and RNA mutational profiles of 43 pathological samples of BMs. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Rui‐Chao, Liu, Xing, Pang, Bo, Liu, Yu‐Qing, Li, Jing‐Jun, Li, Yang‐Fang, Zhao, Zheng, Du, Jiang, Bao, Zhao Shi, Jiang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819346/
https://www.ncbi.nlm.nih.gov/pubmed/34812554
http://dx.doi.org/10.1111/cas.15211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819346/
https://www.ncbi.nlm.nih.gov/pubmed/34812554
http://dx.doi.org/10.1111/cas.15211

Ejemplares similares